Immunic Therapeutics
Entity

  • Immunic Therapeutics

    Created in 2016
  • BETA

    Up & running (A)
    Existing signals show a regular activity

  • Social networks

    595 5,822

  • Activities

    biotech deeptech

  • Technologies

    Synthetic Biology

  • Entity types

    Startup

  • Location

    New York, NY, USA

    New York

    United States of America

  • Employees

    Scale: 51-200

    Estimated: 77

  • Engaged corporates

    1
    0 1

  • Added in Motherbase

    1 year, 3 months ago
Description
  • Value proposition

    Immunic is a biotechnology company developing small molecule therapies for chronic inflammatory and autoimmune diseases

    Immunic (Nasdaq: IMUX) is a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases.

    Privacy Policy: https://imux.com/privacy-policy/

  • Home - Immunic Therapeutics

    Immunic is a clinical-stage biopharmaceutical company with a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimmune diseases.

    • https://imux.com/
Corporate interactions BETA
Corporate TypeTweets Articles
Biotechnology Innovation Organization
Biotechnology Innovation Organization
Biotechnology Innovation Organization
Other

12 Jun 2024


Similar entities
Last news
Show all articles
Social network dynamics